XML 99 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Stockholders' Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Preferred Operating Partnership
Operating Partnership
Other
Par Value
Paid-in Capital
Accumulated Other Comprehensive Deficit
Accumulated Deficit
Comprehensive Income
Balances at Dec. 31, 2008 $ 946,793 $ 29,837 $ 36,628 $ 1,558 $ 858 $ 1,130,964   $ (253,052)  
Balances (in shares) at Dec. 31, 2008         85,790,331        
Increase (Decrease) in Stockholders' Equity                  
Restricted stock grants issued 5       5        
Restricted stock grants issued (in shares)         547,265        
Restricted stock grants cancelled (in shares)         (21,256)        
Compensation expense related to stock-based awards 3,809         3,809      
Noncontrolling interests consolidated as business acquisitions 726     726          
Investments from other noncontrolling interests (615)     (615)          
Repurchase of equity portion of exchangeable senior notes (2,234)         (2,234)      
Redemption of Operating Partnership units for cash (1,908)   (1,908)            
Redemption of Operating Partnership units for common stock     (3,583)   4 3,579      
Redemption of Operating Partnership units for common stock (in shares)         405,501        
Comprehensive income:                  
Net income (loss) 39,093 6,186 1,826 (896)       31,977 39,093
Change in fair value of interest rate swap (1,111) (11) (44)       (1,056)   (1,111)
Total comprehensive income 37,982               37,982
Tax effect from vesting of restricted stock grants and stock option exercises (414)         (414)      
Tax effect from wind down of development program 2,539         2,539      
Distributions to Operating Partnership units held by noncontrolling interests (7,664) (6,126) (1,538)            
Dividends paid on common stock at $0.56, $0.40 and $0.38 per share for the year ended 31st December, 2011, 2010 and 2009, respectively (32,800)             (32,800)  
Balances at Dec. 31, 2009 946,219 29,886 31,381 773 867 1,138,243 (1,056) (253,875)  
Balances (in shares) at Dec. 31, 2009         86,721,841        
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock upon the exercise of options 5,661       5 5,656      
Issuance of common stock upon the exercise of options (in shares)         484,261        
Restricted stock grants issued 4       4        
Restricted stock grants issued (in shares)         445,230        
Restricted stock grants cancelled (in shares)         (64,010)        
Compensation expense related to stock-based awards 4,580         4,580      
Deconsolidation of noncontrolling interests 104     104          
Investments from other noncontrolling interests 87     87          
Purchase of noncontrolling interest 223     223          
Redemption of Operating Partnership units for cash (4,116)   (4,116)            
Comprehensive income:                  
Net income (loss) 33,374 6,048 1,048 (53)       26,331 33,374
Change in fair value of interest rate swap (4,963) (55) (177)       (4,731)   (4,963)
Total comprehensive income 28,411               28,411
Tax effect from vesting of restricted stock grants and stock option exercises 836         836      
Tax effect from contribution of property to Taxable REIT Subsidiary (495)         (495)      
Distributions to Operating Partnership units held by noncontrolling interests (7,479) (6,146) (1,333)            
Dividends paid on common stock at $0.56, $0.40 and $0.38 per share for the year ended 31st December, 2011, 2010 and 2009, respectively (34,964)             (34,964)  
Balances at Dec. 31, 2010 939,071 29,733 26,803 1,134 876 1,148,820 (5,787) (262,508)  
Balances (in shares) at Dec. 31, 2010 87,587,322       87,587,322        
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock upon the exercise of options 18,622       14 18,608      
Issuance of common stock upon the exercise of options (in shares)         1,388,269        
Restricted stock grants issued 2       2        
Restricted stock grants issued (in shares)         226,630        
Restricted stock grants cancelled (in shares)         (47,695)        
Issuance of common stock, net of offering costs 112,349       53 112,296      
Issuance of common stock, net of offering costs (in shares)         5,335,423        
Compensation expense related to stock-based awards 5,757         5,757      
Redemption of Operating Partnership units for cash (271)   (271)            
Redemption of Operating Partnership units for common stock     (2,344)   3 2,341      
Redemption of Operating Partnership units for common stock (in shares)         293,641        
Comprehensive income:                  
Net income (loss) 58,423 6,289 1,689 (4)       50,449 58,423
Change in fair value of interest rate swap (2,237) (22) (66)       (2,149)   (2,237)
Total comprehensive income 56,186               56,186
Tax effect from vesting of restricted stock grants and stock option exercises 2,199         2,199      
Distributions to Operating Partnership units held by noncontrolling interests (8,098) (6,305) (1,793)            
Distributions to other noncontrolling interests (29)     (29)          
Dividends paid on common stock at $0.56, $0.40 and $0.38 per share for the year ended 31st December, 2011, 2010 and 2009, respectively (52,027)             (52,027)  
Balances at Dec. 31, 2011 $ 1,073,761 $ 29,695 $ 24,018 $ 1,101 $ 948 $ 1,290,021 $ (7,936) $ (264,086)  
Balances (in shares) at Dec. 31, 2011 94,783,590       94,783,590